This Federal Supply Schedule contract is an interim agreement awarded to Orchard Therapeutics North America by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs. The contract, which has a ceiling value of $25,000.00, is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024, to March 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle, meaning that the government may award similar contracts to other vendors. The contract does not have any set-aside requirements. The purpose of this contract is to provide the VA with access to a range of pharmaceutical and hematology-related products to support the medical needs of veterans within VISN 12.
Generated 2/11/25, 10:07 AM